1. Home
  2. PDSB vs EDAP Comparison

PDSB vs EDAP Comparison

Compare PDSB & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • EDAP
  • Stock Information
  • Founded
  • PDSB 2005
  • EDAP 1979
  • Country
  • PDSB United States
  • EDAP France
  • Employees
  • PDSB N/A
  • EDAP N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PDSB Health Care
  • EDAP Health Care
  • Exchange
  • PDSB Nasdaq
  • EDAP Nasdaq
  • Market Cap
  • PDSB 84.2M
  • EDAP 81.6M
  • IPO Year
  • PDSB N/A
  • EDAP 1997
  • Fundamental
  • Price
  • PDSB $1.45
  • EDAP $2.17
  • Analyst Decision
  • PDSB Strong Buy
  • EDAP Strong Buy
  • Analyst Count
  • PDSB 3
  • EDAP 1
  • Target Price
  • PDSB $14.00
  • EDAP $19.00
  • AVG Volume (30 Days)
  • PDSB 296.4K
  • EDAP 70.3K
  • Earning Date
  • PDSB 11-14-2024
  • EDAP 11-07-2024
  • Dividend Yield
  • PDSB N/A
  • EDAP N/A
  • EPS Growth
  • PDSB N/A
  • EDAP N/A
  • EPS
  • PDSB N/A
  • EDAP N/A
  • Revenue
  • PDSB N/A
  • EDAP $70,722,730.00
  • Revenue This Year
  • PDSB N/A
  • EDAP $6.96
  • Revenue Next Year
  • PDSB N/A
  • EDAP $15.53
  • P/E Ratio
  • PDSB N/A
  • EDAP N/A
  • Revenue Growth
  • PDSB N/A
  • EDAP 12.17
  • 52 Week Low
  • PDSB $1.30
  • EDAP $2.00
  • 52 Week High
  • PDSB $6.68
  • EDAP $8.50
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 34.16
  • EDAP 45.70
  • Support Level
  • PDSB $1.37
  • EDAP $2.12
  • Resistance Level
  • PDSB $1.50
  • EDAP $2.26
  • Average True Range (ATR)
  • PDSB 0.13
  • EDAP 0.16
  • MACD
  • PDSB 0.00
  • EDAP -0.01
  • Stochastic Oscillator
  • PDSB 28.03
  • EDAP 27.42

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: